⌘K

Login Start Free

Home/Filings/4/0001385508-23-000005

4//SEC Filing

CRYSTAL ROGER 4

Accession 0001385508-23-000005

CIK 0001385508other

View on SEC.gov Company Profile

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 4:52 PM ET

Size

4.8 KB

Accession

0001385508-23-000005

Insider Transaction Report

Form 4

Period: 2023-01-05

OPIANT PHARMACEUTICALS, INC.OPNT

DirectorChief Executive Officer10% Owner

Transactions

Sale
Common Stock
2023-01-05$20.20/sh−5,029$101,586→ 77,880 total

Footnotes (1)

[F1]These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.

Documents

1 file

4
wf-form4_167295549954717.xmlPrimary
FORM 4

Issuer

OPIANT PHARMACEUTICALS, INC.

CIK 0001385508

Entity typeother

Related Parties

1

filerCIK 0001656633

Filing Metadata

Form type: 4
Filed: Jan 4, 7:00 PM ET
Accepted: Jan 5, 4:52 PM ET
Size: 4.8 KB

View on SEC.gov